Simpson Thacher represented Change Healthcare in its acquisition of 100% of the ownership interest in eRx Network (“eRx”), a leading provider of comprehensive, innovative and secure data-driven solutions for pharmacies, for a purchase price of $212.9 million plus cash on the balance sheet. The transaction supports Change Healthcare’s commitment to focus on and invest in core aspects of the business to fuel long-term growth and advance innovation. The addition of eRx brings strategic benefits including a broader solutions portfolio to offer pharmacies, the ability to serve patients, providers and payers more comprehensively and the potential to enter new markets.~~Change Healthcare (Nasdaq: CHNG) is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.~~The Simpson Thacher team included Jonathan Corsico, John Dougherty and Hilary Albrecht (M&A); Gregory Grogan, Andrew Kofsky and Caitlin Lucey (Executive Compensation and Employee Benefits); Andrew Purcell and Edward Grais (Tax); Lori Lesser and Alysha Sekhon (Intellectual Property); Vanessa Burrows (Healthcare); Steven DeLott (Insurance); and Kelly Karapetyan, Kenneth Ehrhard and Nicholas Ingros (Antitrust).